相关实验视频

Updated: Jun 20, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

免疫检查点抑制剂的多器官免疫相关不良事件及其下游影响:一项回顾性多队列研究

Guihong Wan¹, Wenxin Chen², Sara Khattab¹

¹Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

The Lancet. Oncology

|July 18, 2024

概括

了解癌症免疫治疗中的免疫相关不良事件 (irAEs) 是关键. 这项研究发现,特定的irAE集群,如内分泌和皮肤,与更好的生存有关,而其他,如呼吸系统,可能表明较差的结果.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
临床研究临床研究

背景情况:

免疫检查点抑制剂 (ICI) 是一种重要的癌症疗法.
与免疫相关的不良事件 (irAEs) 是ICI的常见副作用.
了解irAE并发症和预后影响对于管理免疫治疗至关重要.

研究的目的:

调查ICI受体中多器官irAEs的同时发生模式.
分析不同irAE集群对生存结果的预后影响.
为了利用大规模的数据,对irAE管理产生可概括的见解.

主要方法:

对ICI受益人的多机构 (MGBD) 和人口级 (TriNetX) 队列的回顾性分析.
倾向性得分匹配以确保队列可比性.
使用已确定的规则识别irAE,然后进行相关性分析,非负矩阵因子化和层次分类,以定义irAE模式和患者群.
具有里程碑意义的整体生存分析 (6个月),以评估已识别的irAE集群的预后影响.

主要成果:

在两个队列中都观察到irrAEs的共同同时发生模式.
确定了七个不同的irAE集群:内分泌,皮肤,呼吸道,胃肠道,肝脏,肌肉骨和神经系统.
在MGBD队列中,内分泌和皮肤irAE集群与有利的6个月整体存活率相关 (HR分别为0.53和0.61). 呼吸道IRAE与不良的生存率相关 (HR1.60).
在TrinetX队列中也观察到类似的生存趋势,内分泌,皮肤和神经的IRAE显示出与生存结果的显著关联.

结论:

确定患者特定的irAE集群提供了有价值的预后信息.
这些发现可以为患者的咨询提供有关其irAE星座的临床影响的信息.
基于这些见解,可以制定针对irAEs的个性化监测和缓解策略.

更多相关视频

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

相关概念视频

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...